Literature DB >> 6306145

Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep.

R Lutley, G Pétursson, P A Pálsson, G Georgsson, J Klein, N Nathanson.   

Abstract

A group of 20 Icelandic sheep were infected intracerebrally with visna virus strain 1514, and 209 virus isolates were obtained from the blood, cerebrospinal fluid, and central nervous system (CNS) over a period of 7 years, during which eight animals developed clinical signs of visna necessitating sacrifice. (i) Using type-specific antisera, it was found that 12 (16%) of 76 isolates tested escaped neutralization. These 12 variant viruses were distributed randomly among animals and over time, and did not replace the infecting strain even though all sheep developed homotypic antibody within 3 months of infection. The one exception was sheep no. 1557 (an animal without clinical visna), where the last six isolates were variants. (ii) A total of 35 blood and CNS isolates from seven of these sheep (including five with clinical visna) were tested against serial samples of their own sera. Autologous antisera neutralized all isolates tested with the exception of isolates from sheep 1557. None of the isolates obtained at sacrifice from the five sheep with clinical visna escaped neutralization with autologous antisera. These data suggest that although variant viruses are encountered at considerable frequency during long-term infection of Icelandic sheep, the variants usually do not replace the infecting strain. Antigenic drift does not appear to be essential for virus persistence or for the development of clinically evident CNS lesions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306145     DOI: 10.1099/0022-1317-64-7-1433

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  17 in total

1.  Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus.

Authors:  S Alexandersen; S Carpenter
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus.

Authors:  S Carpenter; S Alexandersen; M J Long; S Perryman; B Chesebro
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 3.  Pathogenesis of lentivirus-induced arthritis. A review.

Authors:  S Kennedy-Stoskopf
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  Role of the host immune response in selection of equine infectious anemia virus variants.

Authors:  S Carpenter; L H Evans; M Sevoian; B Chesebro
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.

Authors:  O Salinovich; S L Payne; R C Montelaro; K A Hussain; C J Issel; K L Schnorr
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

6.  Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence.

Authors:  S Kennedy-Stoskopf; O Narayan
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

7.  Antigenic variants of Junín virus isolated from infected Calomys musculinus. Brief report.

Authors:  L E Alché; C E Coto
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 8.  Animal virus infections that defy vaccination: equine infectious anemia, caprine arthritis-encephalitis, maedi-visna, and feline infectious peritonitis.

Authors:  N C Pedersen
Journal:  Adv Vet Sci Comp Med       Date:  1989

9.  Evidence for recombination in the envelope gene of maedi-visna virus.

Authors:  Valgerdur Andrésdóttir
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

10.  Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1.

Authors:  R Bernier; M Tremblay
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.